Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells

The nitric oxide (NO) prodrug JS-K is shown to have anticancer activity. To profile the molecular events associated with anticancer effects of JS-K, HL-60 leukemia cells were treated with JS-K and subjected to microarray and real-time RT-PCR analysis. JS-K induced concentration- and time-dependent g...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Liu, Jie, Malavya, Swati, Wang, Xueqian, Saavedra, Joseph E., Keefer, Larry K., Tokar, Erik, Qu, Wei, Waalkes, Michael P., Shami, Paul J.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496159/
https://ncbi.nlm.nih.gov/pubmed/19348908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygeno.2009.03.005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items